LCD 125 Tablet is a precursor of dopamine (chemical messenger in the brain) primarily used in the treatment of Parkinson’s disease with its symptoms including tremors, spasms, muscle stiffness, and poor muscle control.

Feb 20, 2025 · LCD 100mg/25mg Tablet is one of the most effective medications to relieve symptoms of Parkinson's disease such as tremors, muscle stiffness, and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in the coordination of body movements.

LCD-125 Tablet is a combination of Levodopa and Carbidopa. It is used to treat the symptoms of Parkinson's disease (a brain disorder that affects movement with symptoms such as tremors, shakiness, stiffness, difficulty in walking, impaired balance and coordination, etc.).

Dec 9, 2022 · LCD 125 Tablet It is used to manage the signs and symptoms of Parkinsonism (such as rigidity, tremor, dyskinesia). View LCD 125 Tablet 10'S uses, substitutes, side effects, composition, directions for use, drug interactions, precautions and buy online at best price. Get COD Doorstep Delivery.

LCD 125 tablet is used for the management and improvement of signs and symptoms associated with Parkinson’s disease like muscle spasms, tremors, stiffness of muscles, shaking of hands and feet, etc.

Jan 7, 2025 · Levodopa and carbidopa is used for the treatment of Parkinson's disease, post-encephalitic Parkinsonism, and symptomatic Parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

Aug 8, 2019 · LCD (125) 100/25mg - 10 Tablets (Carbidopa-Levodopa ) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes . It is manufactured by...

Buy Lcd 100/25 MG Tablet online at Truemeds used to treat parkinson’s disease. Lcd 100/25 MG substitutes, composition, side-effects, price, expert advise.

Buy LCD 125 Tablet (10 Tab) online. Know the Price, Warnings, Precautions, Side Effects, Alternatives & How it Works for LCD 125 Tablet (10 Tab) manufactured by Intas Pharmaceuticals Ltd. (A1)